Comparison of benign and malignant insulinoma.

Am J Surg 2020 Aug 16

Comparison of benign and malignant insulinoma.

Related Questions

Do you have a preferred systemic agent for patients with metastatic, unresectable, functional neuroendocrine tumors, such as an insulinoma, if the goal is to get a quick response?

New comment by Medical Oncologist at Bon Secours Saint Mary's Hospital ( July 22, 2021)

Thank you. This is very helpful!

Read more (3 Answers available)